Skip to main content
. 2022 Jan 22;10(2):234. doi: 10.3390/biomedicines10020234

Figure 2.

Figure 2

Low expression of tyrosine-metabolizing enzymes is associated with poor prognosis in HCC patients. The tyrosine-metabolizing enzymes ((A)-TAT, (B)-HPD, (C)-HGD, (D)-GSTZ1, and (E)-FAH) mRNA expression levels between tumor (of different grades) and normal tissues in patients with HCC in TGCA database. Overall survival of patients with HCC grouped by tyrosine-metabolizing enzymes’ expression through the Kaplan-Meier Plotter online analysis tool.